Medical Care

Global Mid-Size Pharmaceutical Market Research Report 2025

The global market for Mid-Size Pharmaceutical was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mid-Size Pharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mid-Size Pharmaceutical.
The Mid-Size Pharmaceutical market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mid-Size Pharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mid-Size Pharmaceutical companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
DAIICHI SANKYO COMPANY LIMITED
Eisai Co., Ltd.
Bausch Health Companies Inc.
Regeneron Pharmaceuticals, Inc
Sun Pharmaceutical Industries Ltd
Alexion Pharmaceuticals, Inc.
Mallinckrodt
Endo Pharmaceuticals Inc.
Les Laboratories Servier
UCB S.A.
Segment by Type
Prescription
Over-the-Counter (OTC)
Segment by Application
Cardiovascular Diseases
Pain Management
Diabetes
Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mid-Size Pharmaceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mid-Size Pharmaceutical Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prescription
1.2.3 Over-the-Counter (OTC)
1.3 Market by Application
1.3.1 Global Mid-Size Pharmaceutical Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cardiovascular Diseases
1.3.3 Pain Management
1.3.4 Diabetes
1.3.5 Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mid-Size Pharmaceutical Market Perspective (2020-2031)
2.2 Global Mid-Size Pharmaceutical Growth Trends by Region
2.2.1 Global Mid-Size Pharmaceutical Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Mid-Size Pharmaceutical Historic Market Size by Region (2020-2025)
2.2.3 Mid-Size Pharmaceutical Forecasted Market Size by Region (2026-2031)
2.3 Mid-Size Pharmaceutical Market Dynamics
2.3.1 Mid-Size Pharmaceutical Industry Trends
2.3.2 Mid-Size Pharmaceutical Market Drivers
2.3.3 Mid-Size Pharmaceutical Market Challenges
2.3.4 Mid-Size Pharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mid-Size Pharmaceutical Players by Revenue
3.1.1 Global Top Mid-Size Pharmaceutical Players by Revenue (2020-2025)
3.1.2 Global Mid-Size Pharmaceutical Revenue Market Share by Players (2020-2025)
3.2 Global Mid-Size Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Mid-Size Pharmaceutical Revenue
3.4 Global Mid-Size Pharmaceutical Market Concentration Ratio
3.4.1 Global Mid-Size Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mid-Size Pharmaceutical Revenue in 2024
3.5 Global Key Players of Mid-Size Pharmaceutical Head office and Area Served
3.6 Global Key Players of Mid-Size Pharmaceutical, Product and Application
3.7 Global Key Players of Mid-Size Pharmaceutical, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mid-Size Pharmaceutical Breakdown Data by Type
4.1 Global Mid-Size Pharmaceutical Historic Market Size by Type (2020-2025)
4.2 Global Mid-Size Pharmaceutical Forecasted Market Size by Type (2026-2031)
5 Mid-Size Pharmaceutical Breakdown Data by Application
5.1 Global Mid-Size Pharmaceutical Historic Market Size by Application (2020-2025)
5.2 Global Mid-Size Pharmaceutical Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Mid-Size Pharmaceutical Market Size (2020-2031)
6.2 North America Mid-Size Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Mid-Size Pharmaceutical Market Size by Country (2020-2025)
6.4 North America Mid-Size Pharmaceutical Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mid-Size Pharmaceutical Market Size (2020-2031)
7.2 Europe Mid-Size Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Mid-Size Pharmaceutical Market Size by Country (2020-2025)
7.4 Europe Mid-Size Pharmaceutical Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mid-Size Pharmaceutical Market Size (2020-2031)
8.2 Asia-Pacific Mid-Size Pharmaceutical Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Mid-Size Pharmaceutical Market Size by Region (2020-2025)
8.4 Asia-Pacific Mid-Size Pharmaceutical Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mid-Size Pharmaceutical Market Size (2020-2031)
9.2 Latin America Mid-Size Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Mid-Size Pharmaceutical Market Size by Country (2020-2025)
9.4 Latin America Mid-Size Pharmaceutical Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mid-Size Pharmaceutical Market Size (2020-2031)
10.2 Middle East & Africa Mid-Size Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Mid-Size Pharmaceutical Market Size by Country (2020-2025)
10.4 Middle East & Africa Mid-Size Pharmaceutical Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 DAIICHI SANKYO COMPANY LIMITED
11.1.1 DAIICHI SANKYO COMPANY LIMITED Company Details
11.1.2 DAIICHI SANKYO COMPANY LIMITED Business Overview
11.1.3 DAIICHI SANKYO COMPANY LIMITED Mid-Size Pharmaceutical Introduction
11.1.4 DAIICHI SANKYO COMPANY LIMITED Revenue in Mid-Size Pharmaceutical Business (2020-2025)
11.1.5 DAIICHI SANKYO COMPANY LIMITED Recent Development
11.2 Eisai Co., Ltd.
11.2.1 Eisai Co., Ltd. Company Details
11.2.2 Eisai Co., Ltd. Business Overview
11.2.3 Eisai Co., Ltd. Mid-Size Pharmaceutical Introduction
11.2.4 Eisai Co., Ltd. Revenue in Mid-Size Pharmaceutical Business (2020-2025)
11.2.5 Eisai Co., Ltd. Recent Development
11.3 Bausch Health Companies Inc.
11.3.1 Bausch Health Companies Inc. Company Details
11.3.2 Bausch Health Companies Inc. Business Overview
11.3.3 Bausch Health Companies Inc. Mid-Size Pharmaceutical Introduction
11.3.4 Bausch Health Companies Inc. Revenue in Mid-Size Pharmaceutical Business (2020-2025)
11.3.5 Bausch Health Companies Inc. Recent Development
11.4 Regeneron Pharmaceuticals, Inc
11.4.1 Regeneron Pharmaceuticals, Inc Company Details
11.4.2 Regeneron Pharmaceuticals, Inc Business Overview
11.4.3 Regeneron Pharmaceuticals, Inc Mid-Size Pharmaceutical Introduction
11.4.4 Regeneron Pharmaceuticals, Inc Revenue in Mid-Size Pharmaceutical Business (2020-2025)
11.4.5 Regeneron Pharmaceuticals, Inc Recent Development
11.5 Sun Pharmaceutical Industries Ltd
11.5.1 Sun Pharmaceutical Industries Ltd Company Details
11.5.2 Sun Pharmaceutical Industries Ltd Business Overview
11.5.3 Sun Pharmaceutical Industries Ltd Mid-Size Pharmaceutical Introduction
11.5.4 Sun Pharmaceutical Industries Ltd Revenue in Mid-Size Pharmaceutical Business (2020-2025)
11.5.5 Sun Pharmaceutical Industries Ltd Recent Development
11.6 Alexion Pharmaceuticals, Inc.
11.6.1 Alexion Pharmaceuticals, Inc. Company Details
11.6.2 Alexion Pharmaceuticals, Inc. Business Overview
11.6.3 Alexion Pharmaceuticals, Inc. Mid-Size Pharmaceutical Introduction
11.6.4 Alexion Pharmaceuticals, Inc. Revenue in Mid-Size Pharmaceutical Business (2020-2025)
11.6.5 Alexion Pharmaceuticals, Inc. Recent Development
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Details
11.7.2 Mallinckrodt Business Overview
11.7.3 Mallinckrodt Mid-Size Pharmaceutical Introduction
11.7.4 Mallinckrodt Revenue in Mid-Size Pharmaceutical Business (2020-2025)
11.7.5 Mallinckrodt Recent Development
11.8 Endo Pharmaceuticals Inc.
11.8.1 Endo Pharmaceuticals Inc. Company Details
11.8.2 Endo Pharmaceuticals Inc. Business Overview
11.8.3 Endo Pharmaceuticals Inc. Mid-Size Pharmaceutical Introduction
11.8.4 Endo Pharmaceuticals Inc. Revenue in Mid-Size Pharmaceutical Business (2020-2025)
11.8.5 Endo Pharmaceuticals Inc. Recent Development
11.9 Les Laboratories Servier
11.9.1 Les Laboratories Servier Company Details
11.9.2 Les Laboratories Servier Business Overview
11.9.3 Les Laboratories Servier Mid-Size Pharmaceutical Introduction
11.9.4 Les Laboratories Servier Revenue in Mid-Size Pharmaceutical Business (2020-2025)
11.9.5 Les Laboratories Servier Recent Development
11.10 UCB S.A.
11.10.1 UCB S.A. Company Details
11.10.2 UCB S.A. Business Overview
11.10.3 UCB S.A. Mid-Size Pharmaceutical Introduction
11.10.4 UCB S.A. Revenue in Mid-Size Pharmaceutical Business (2020-2025)
11.10.5 UCB S.A. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Mid-Size Pharmaceutical Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Prescription
Table 3. Key Players of Over-the-Counter (OTC)
Table 4. Global Mid-Size Pharmaceutical Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Mid-Size Pharmaceutical Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Mid-Size Pharmaceutical Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Mid-Size Pharmaceutical Market Share by Region (2020-2025)
Table 8. Global Mid-Size Pharmaceutical Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Mid-Size Pharmaceutical Market Share by Region (2026-2031)
Table 10. Mid-Size Pharmaceutical Market Trends
Table 11. Mid-Size Pharmaceutical Market Drivers
Table 12. Mid-Size Pharmaceutical Market Challenges
Table 13. Mid-Size Pharmaceutical Market Restraints
Table 14. Global Mid-Size Pharmaceutical Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Mid-Size Pharmaceutical Market Share by Players (2020-2025)
Table 16. Global Top Mid-Size Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mid-Size Pharmaceutical as of 2024)
Table 17. Ranking of Global Top Mid-Size Pharmaceutical Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Mid-Size Pharmaceutical Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Mid-Size Pharmaceutical, Headquarters and Area Served
Table 20. Global Key Players of Mid-Size Pharmaceutical, Product and Application
Table 21. Global Key Players of Mid-Size Pharmaceutical, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Mid-Size Pharmaceutical Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Mid-Size Pharmaceutical Revenue Market Share by Type (2020-2025)
Table 25. Global Mid-Size Pharmaceutical Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Mid-Size Pharmaceutical Revenue Market Share by Type (2026-2031)
Table 27. Global Mid-Size Pharmaceutical Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Mid-Size Pharmaceutical Revenue Market Share by Application (2020-2025)
Table 29. Global Mid-Size Pharmaceutical Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Mid-Size Pharmaceutical Revenue Market Share by Application (2026-2031)
Table 31. North America Mid-Size Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Mid-Size Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Mid-Size Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Mid-Size Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Mid-Size Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Mid-Size Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Mid-Size Pharmaceutical Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Mid-Size Pharmaceutical Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Mid-Size Pharmaceutical Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Mid-Size Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Mid-Size Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Mid-Size Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Mid-Size Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Mid-Size Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Mid-Size Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)
Table 46. DAIICHI SANKYO COMPANY LIMITED Company Details
Table 47. DAIICHI SANKYO COMPANY LIMITED Business Overview
Table 48. DAIICHI SANKYO COMPANY LIMITED Mid-Size Pharmaceutical Product
Table 49. DAIICHI SANKYO COMPANY LIMITED Revenue in Mid-Size Pharmaceutical Business (2020-2025) & (US$ Million)
Table 50. DAIICHI SANKYO COMPANY LIMITED Recent Development
Table 51. Eisai Co., Ltd. Company Details
Table 52. Eisai Co., Ltd. Business Overview
Table 53. Eisai Co., Ltd. Mid-Size Pharmaceutical Product
Table 54. Eisai Co., Ltd. Revenue in Mid-Size Pharmaceutical Business (2020-2025) & (US$ Million)
Table 55. Eisai Co., Ltd. Recent Development
Table 56. Bausch Health Companies Inc. Company Details
Table 57. Bausch Health Companies Inc. Business Overview
Table 58. Bausch Health Companies Inc. Mid-Size Pharmaceutical Product
Table 59. Bausch Health Companies Inc. Revenue in Mid-Size Pharmaceutical Business (2020-2025) & (US$ Million)
Table 60. Bausch Health Companies Inc. Recent Development
Table 61. Regeneron Pharmaceuticals, Inc Company Details
Table 62. Regeneron Pharmaceuticals, Inc Business Overview
Table 63. Regeneron Pharmaceuticals, Inc Mid-Size Pharmaceutical Product
Table 64. Regeneron Pharmaceuticals, Inc Revenue in Mid-Size Pharmaceutical Business (2020-2025) & (US$ Million)
Table 65. Regeneron Pharmaceuticals, Inc Recent Development
Table 66. Sun Pharmaceutical Industries Ltd Company Details
Table 67. Sun Pharmaceutical Industries Ltd Business Overview
Table 68. Sun Pharmaceutical Industries Ltd Mid-Size Pharmaceutical Product
Table 69. Sun Pharmaceutical Industries Ltd Revenue in Mid-Size Pharmaceutical Business (2020-2025) & (US$ Million)
Table 70. Sun Pharmaceutical Industries Ltd Recent Development
Table 71. Alexion Pharmaceuticals, Inc. Company Details
Table 72. Alexion Pharmaceuticals, Inc. Business Overview
Table 73. Alexion Pharmaceuticals, Inc. Mid-Size Pharmaceutical Product
Table 74. Alexion Pharmaceuticals, Inc. Revenue in Mid-Size Pharmaceutical Business (2020-2025) & (US$ Million)
Table 75. Alexion Pharmaceuticals, Inc. Recent Development
Table 76. Mallinckrodt Company Details
Table 77. Mallinckrodt Business Overview
Table 78. Mallinckrodt Mid-Size Pharmaceutical Product
Table 79. Mallinckrodt Revenue in Mid-Size Pharmaceutical Business (2020-2025) & (US$ Million)
Table 80. Mallinckrodt Recent Development
Table 81. Endo Pharmaceuticals Inc. Company Details
Table 82. Endo Pharmaceuticals Inc. Business Overview
Table 83. Endo Pharmaceuticals Inc. Mid-Size Pharmaceutical Product
Table 84. Endo Pharmaceuticals Inc. Revenue in Mid-Size Pharmaceutical Business (2020-2025) & (US$ Million)
Table 85. Endo Pharmaceuticals Inc. Recent Development
Table 86. Les Laboratories Servier Company Details
Table 87. Les Laboratories Servier Business Overview
Table 88. Les Laboratories Servier Mid-Size Pharmaceutical Product
Table 89. Les Laboratories Servier Revenue in Mid-Size Pharmaceutical Business (2020-2025) & (US$ Million)
Table 90. Les Laboratories Servier Recent Development
Table 91. UCB S.A. Company Details
Table 92. UCB S.A. Business Overview
Table 93. UCB S.A. Mid-Size Pharmaceutical Product
Table 94. UCB S.A. Revenue in Mid-Size Pharmaceutical Business (2020-2025) & (US$ Million)
Table 95. UCB S.A. Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report


List of Figures
Figure 1. Mid-Size Pharmaceutical Picture
Figure 2. Global Mid-Size Pharmaceutical Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mid-Size Pharmaceutical Market Share by Type: 2024 VS 2031
Figure 4. Prescription Features
Figure 5. Over-the-Counter (OTC) Features
Figure 6. Global Mid-Size Pharmaceutical Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Mid-Size Pharmaceutical Market Share by Application: 2024 VS 2031
Figure 8. Cardiovascular Diseases Case Studies
Figure 9. Pain Management Case Studies
Figure 10. Diabetes Case Studies
Figure 11. Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Mid-Size Pharmaceutical Report Years Considered
Figure 14. Global Mid-Size Pharmaceutical Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Mid-Size Pharmaceutical Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Mid-Size Pharmaceutical Market Share by Region: 2024 VS 2031
Figure 17. Global Mid-Size Pharmaceutical Market Share by Players in 2024
Figure 18. Global Top Mid-Size Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mid-Size Pharmaceutical as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Mid-Size Pharmaceutical Revenue in 2024
Figure 20. North America Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Mid-Size Pharmaceutical Market Share by Country (2020-2031)
Figure 22. United States Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Mid-Size Pharmaceutical Market Share by Country (2020-2031)
Figure 26. Germany Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Mid-Size Pharmaceutical Market Share by Region (2020-2031)
Figure 34. China Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Mid-Size Pharmaceutical Market Share by Country (2020-2031)
Figure 42. Mexico Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Mid-Size Pharmaceutical Market Share by Country (2020-2031)
Figure 46. Turkey Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Mid-Size Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. DAIICHI SANKYO COMPANY LIMITED Revenue Growth Rate in Mid-Size Pharmaceutical Business (2020-2025)
Figure 50. Eisai Co., Ltd. Revenue Growth Rate in Mid-Size Pharmaceutical Business (2020-2025)
Figure 51. Bausch Health Companies Inc. Revenue Growth Rate in Mid-Size Pharmaceutical Business (2020-2025)
Figure 52. Regeneron Pharmaceuticals, Inc Revenue Growth Rate in Mid-Size Pharmaceutical Business (2020-2025)
Figure 53. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Mid-Size Pharmaceutical Business (2020-2025)
Figure 54. Alexion Pharmaceuticals, Inc. Revenue Growth Rate in Mid-Size Pharmaceutical Business (2020-2025)
Figure 55. Mallinckrodt Revenue Growth Rate in Mid-Size Pharmaceutical Business (2020-2025)
Figure 56. Endo Pharmaceuticals Inc. Revenue Growth Rate in Mid-Size Pharmaceutical Business (2020-2025)
Figure 57. Les Laboratories Servier Revenue Growth Rate in Mid-Size Pharmaceutical Business (2020-2025)
Figure 58. UCB S.A. Revenue Growth Rate in Mid-Size Pharmaceutical Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies